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We present evidence suggesting that nonenzymatic, spontaneous hydrolysis of a 
thioester bond  in  native C3  constitutes the  initial event  in  the  activation of the 
alternative pathway. 
It has been known since the original description of C3 that the hemolytic activity 
of the isolated protein decays spontaneously in aqueous solution at a slow rate (1). 
This decay was greatly accelerated by chaotropic agents (2). It has also been known 
that treatment of C3 with simple amines such as hydrazine abolished its hemolytic 
activity (3). Recently, evidence has accumulated that strongly supports the existence 
of an intramolecular thioester bond in native C3 (4-8).  Modification of the thioester 
by incorporation of 1 mol of methylamine destroyed the potential of C3 to bind to 
biological  targets of complement, induced conformational changes in the molecule 
(9)  and led to the expression  of functional binding sites  for complement proteins 
resembling those of enzymatically generated C3b (4,  10). Methylamine-modified  C3 
[C3(CHsNH2)] 1 was shown (4)  to bind Factor B and properdin and was susceptible 
to cleavage and inactivation by Factors H and I. 
The  present  study was  performed  to  investigate the  spontaneous decay of the 
binding potential of native C3 and to determine whether hydrolysis of the thioester 
bond in C3 generates, without any further chemical or enzymatic modification, C3b- 
like  functional properties.  Because  chaotropic  agents  facilitate access of water to 
relatively concealed groups  by perturbing the tertiary structure of proteins,  these 
agents were used to accelerate the spontaneous decay of C3. Chaotrope-treated C3 
that has acquired C3b-like functions on the basis of this treatment will be tentatively 
designated C3(H20). This denotation proposes that this form of C3 contains, instead 
of the thioester bond, a free sulfhydryl and carboxyl group. 
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1 Abbreviations used in this paper: C3(CHaNH~),  C3 hemolytically inactivated by incorporation of methyl- 
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Materials  and  Methods 
Purified Proteins.  C3  (11),  Factor  B  (12),  Factor  D  (13),  Factor  H  (14),  Factor  I  (14), 
properdin  (15),  and  nephritic  factor  (16)  were  purified  from  human  plasma  or  serum  as 
previously described,  n-(Tosylamido 2-phenyl)ethyl chloromethyl  ketone-treated  trypsin  was 
obtained from Worthington Biochemical Corp., Freehold, N. J. Soybean trypsin inhibitor was 
obtained from Sigma Chemical Co., St. Louis, Mo. 
Reagents.  Organomercuria~ substituted agarose (Affi-Gel 501)  and dithiothreitol were pur- 
chased  from  Bio-Rad  Laboratories,  Richmond,  Calif.  Guanidine  (grade  I),  Trizma  base 
(Tris),  methylamine,  and  5,5'-dithiobis-(2-nitrobenzoic  acid)  (DTNB)  were  purchased  from 
Sigma Chemical Co. Sodium dodecyl sulfate (SDS) and iodoacetamide were purchased from 
Pierce Chemical Co., Rockford, Ill. KSCN and urea were purchased from Mallinckrodt,  Inc., 
St. Louis, Mo. 
Buffers.  Buffers used were:  sodium veronal  (10  mM)  -buffered saline  (140  mM),  pH  7.3, 
(VBS); VBS containing 0.1% gelatin; GVB containing  10 mM EDTA; sodium phosphate (10 
raM) -buffered saline (140 mM), pH 7.3; Tris (10 raM) -buffered saline (140 mM), pH 7.3. 
Preparation of Modified Forms of C3.  Native C3 was prepared from isolated C3 (11) by passage 
over organomercurial agarose. This C3 was used for all of the following modified C3 prepara- 
tions and  each had  a  final C3 concentration  of 0.5  mg/ml. C3b was prepared by treatment 
with 5 #g/ml trypsin  (3 min, 37°C),  followed by 10 #g/ml soybean trypsin inhibitor.  C3 was 
rendered hemolytically inactive by freezing (-35°C)  and thawing  (21°C)  slowly eight times. 
C3 was treated with 0.33 M  KSCN, 0.8 M guanidine, 2.8 M urea, or 0.1 M methylamine at pH 
7.3 in VBS for 60 min at 37°C and then dialyzed against VBS. 
Preparation of Affinity-purified Anti-C3a.  Antiserum was raised to purified human C3a (17) in 
a goat. Affinity-purified anti-C3a was prepared by passage of the antiserum over a  Sepharose 
column containing covalently attached, purified C3a (4). The bound antibody was eluted with 
0.1 M  glycine-HC1, pH 2.3. 
Electrophoresis.  Eleetrophoresis in the presence of SDS was performed in 9% polyacrylamide 
gels using the Canaleo SAGE electrophoretie system from Miles Laboratories,  Inc., Elkhart, 
Ind. Immunoelectrophoresis was performed in  1.2% agarose and a buffer containing Tris (38 
mM), glycine (100 mM), and EDTA (10 mM) at pH 8.9. 
Assays.  C3 assays were performed by effective molecule titration described previously (18). 
The activity of the fluid-phase nephritic factor-stabilized C3 convertase was determined by the 
rate of C3 consumption  at 37°C.  Sulthydryl  titrations  using Ellman's reagent  (DTNB)  were 
performed in 50 mM sodium phosphate, pH 7.4, using a Cary 219 spectrophotometer (Varian 
Associates,  Inc.  Palo  Alto,  Calif.).  The reaction  of DTNB  with  free sulfhydryl  groups was 
followed at 412 nm and calculations used the reported extinction coefficient,  1.36 ×  104 M -~ 
cm  -1 (19). 
Results 
Rate of Spontaneous Decay of C3 Hemolytic Activity.  As demonstrated  in Fig.  1, native 
C3 slowly loses hemolytic activity when incubated  at 37°C. The rate was determined 
to  be  between  0.2  and  0.4%/h  (Table  I)  in  the  presence  or  absence  of metal  ions, 
azide, or the protease inhibitor  benzamidine.  The rate was significantly  increased  in 
the  presence  of 0.1  M  imidazole,  but  it  is not  clear whether  imidazole  acts nucleo- 
philically  or by another  mechanism.  In the presence of physiological  concentrations 
of Factors B, D, and  Mg  +÷, formation of C3 convertase was uncontrolled  and all C3 
hemolytic  activity  was  lost  in  less  than  2  min.  The  presence  of Factors  H  and  I, 
however, provided an efficient control system and a  mixture containing physiological 
concentrations  of all  five components  (C3,  B,  D,  H,  and  I)  exhibited  a  rate  of C3 
inactivation  of l%/h  (Fig.  1). 
Enhancement of Spontaneous Decay of C3 Hemolytic Activity by Chaotropic Agents.  Fig.  2 
documents the effect of low concentrations  of KSCN on C3 hemolytic activity. In the 
presence of 0.33 M  KSCN, the rate of C3 inactivation was 6.25%/min compared with 858  INITIATION OF THE  ALTERNATIVE  PATHWAY  OF COMPLEMENT 
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Fro.  1.  The  rate  of inactivation  of C3  hemolytic  activity in  water.  Hemolytic  activity was 
determined after long-term  incubation  at 37°C in VBS containing 0.5 mM magnesium. C3 was 
incubated alone (0) at physiological concentration  (1,200 #g/ml) or in the presence of Factors B 
(200 #g/ml) and D (2 ~g/ml) (O). Incubations containing the complete five-protein system (&) were 
prepared by inclusion of physiological concentrations of the control proteins C3b inactivator (Factor 
I, 34/~g/ml) and/~IH (Factor H, 465 ~g/ml) in the mixture containing C3 and Factors B and D. 
TABLE  I 
Rate of Loss of C3 Hemolytic Activity during 66 Hours at 37°C in Water 
Buffer  Activity loss 
VBS, Mg  ++ 
VBS, Mg  ÷+, Ca  ++, Ns- 
VBS, Mg  ++, Ca  ++, Na  +, benzamidine 
VBS, EDTA, Nz-, benzamidine 
VBS, EDTA, Ns-, benzamidine, imidazole 
%lh 
0.4 
0.2 
0.2 
0.3 
0.8 
Concentrations:  C3,  1.2 mg/ml; Mg  ++ alone, 1.5 raM; Ca  ++ and Mg  ++, 0.15 
and 0.5 mM, respectively; EDTA,  l0 mM; sodium azide, 0.1%; benzamidine, 
10 raM; imidazole, 0.1 M. In the experiment with magnesium alone, the last 
sample analyzed was taken after only 24 h. 
a rate of 0.005%/min  in buffer (Table I). The rate of inactivation was therefore 1,250- 
fold enhanced  under these conditions. Similar effects were seen with nonionic  (urea) 
and cationic (guanidine) chaotropic agents (Fig. 3). The fact that all three chaotropes 
had similar effects suggests that inactivation was not the result of a specific sensitivity 
of C3  to  a  particular agent.  The  low  concentrations  found  to  be  effective do  not 
usually cause irreversible denaturation of secondary or tertiary protein structure. 
Synchronous Appearance of a SulJhydryl (SH) Group in C3 with Loss of C3 Hemolytic Activity 
During Treatment with Chaotropic Agents.  It has previously been shown  (4, 6, 8) that the 
reaction of C3 with methylamine results in the simultaneous loss of hemolytic activity 
and the incorporation of 1 tool of methylamine per mol of C3. This reaction has been 
shown  to  expose  a  titratable  SH  group.  Fig.  4  demonstrates  that  inactivation  by 
methylamine and exposure of a  single SH group are simultaneous events. Treatment 
of native C3 with  KSCN  to enhance  the spontaneous decay resulted in the simulta- 
neous  appearance  of  SH  and  loss  of  hemolytic  activity  (Fig.  5).  Although  the M.  K.  PANGBURN, R.  D.  SCHREIBER,  AND H. J.  MULLER-EBERHARD  859 
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Fro.  2.  Enhanced inactivation of C3 in the presence of the chaotropic agent KSCN. Native C3 
was incubated with 0.22 M (A), 0.33 M (O), or 0.5 M (0) KSCN in VBS at 37°C. Samples were 
removed at various times, diluted 100-fold in cold VBS containing gelatin and EDTA, and assayed 
for C3 hemolytic activity. 
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Fro.  3.  Enhanced inactivation of C3 in the presence  of urea or guanidine. Native C3 was incubated 
with 2.5 M urea (&), 2.7 M urea (A), 0.75 M guanidine (O), or 0.82 M guanidine (O) in VBS at 
37°C. Samples were removed at the indicated times, diluted 100-fold  in cold VBS containing gelatin 
and EDTA, and assayed for C3 hemolytic activity. 
maximum  exposure  of  SH  per  mol  C3  was  less  than  1  when  a  relatively  high 
concentration of  KSCN  was  used  (0.5  M),  the  kinetics  of  inactivation and  SH 
appearance were identical, i.e., 50% inactivation corresponded to exposure of half of 
the maximum amount of SH observed. Table II compares the hemolytic activity and 
free SH content of C3 subjected to six different treatments that result in loss of C3 
hemolytic activity. Proteolytic conversion of C3 to C3b liberated 1 mol SH per mol 
C3b.  Repeated  freezing  and  thawing  also  exposed  1  mol  SH  per  mol  C3.  Low 
concentrations of KSCN  or  guanidine liberated  0.75  and  0.72  tool  SH  per  mol 
protein, respectively. Treatment with urea led to inactivation of hemolytic activity 
but no SH appearance, possibly because of further denaturation. 
Separation  of Native  C3 from  Hemolytically  Inactive, SH-containing  C3  Derivatives  on 
Organomercurial Agarose.  The  majority  of  the  hemolytically inactive  forms  of  C3 860  INITIATION OF THE  ALTERNATIVE PATHWAY OF COMPLEMENT  .lO:o  
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Fio.  4.  Synchronous appearance of a free SH group in C3 and inactivation of hemolytic activity 
during incubation with methylamine. C3 (1 mg/ml) was incubated with 100 mM methylamine in 
50 mM sodium phosphate buffer, pH 8.0, at 22°C. The reaction with DTNB (14 #M) was followed 
continuously at 412 nm. Aliquots were removed at the indicated times, diluted 100-fold in cold VBS 
containing gelatin and EDTA, and assayed  for C3 hemolytic activity. 
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FIc.  5.  Appearance of a  free SH group during chaotrope-accelerated hemolytic inactivation of 
C3. C3 (1 mg/ml) was incubated with 0.5 M KSCN in 50 mM sodium phosphate buffer,  pH 7.4, 
at 22°C (closed symbols). The reaction with DTNB (14 #M) was followed continuously at 412 nm. 
Aliquots were removed at the indicated times, diluted 100-fold in cold VBS containing gelatin and 
EDTA, and  assayed  for C3  hemolytic activity. The control  experiment  (open  symbols)  lacking 
KSCN was performed in a similar manner. 
generated during purification,  storage,  freezing and thawing contain a  single free SH 
group.  Complete  removal of this  material  from  hemolytically active,  native  C3  was 
achieved by passage  of the protein  through  agarose  bearing  a  covalently coupled p- 
mercurianiline derivative.  2 Native C3 was not bound  to the organomercurial agarose. 
It eluted immediately behind a  small amount  of inactive, aggregated C3 (Fig. 6). The 
specific  hemolytic  activity  of the  C3  sample  applied  to  the  column  had  decreased 
during  storage  at  -35°C  to  23%  of that  of native  C3.  The  specific  activity  of the 
~Two  forms  of organomercurial  agarose  are  commercially available.  Aft-Gel  501  from  Bio-Rad 
Laboratories, has a spacer six atoms longer than the product from Sigma Chemical Co., and only the Bio- 
Rad material binds SH-containing derivatives of C3. M.  K.  PANGBURN,  R.  D.  SCHREIBER,  AND H. J.  MULLER-EBERHARD 
TABLE II 
Hemolytic Activity  and Free SH Content of Freeze-thawed  or Chaotrope-treated C3" 
861 
C3  C3  C3  C3  C3  C3  (Guana-  (Native)  C3b  (Freeze-  (KSCN)  (Urea)  (CH3NH2) 
thawed)  dine) 
Hemolytic activity:]:  95  0  6  0  0  0  0 
Moles SH/mole C3§  0.15  1.01  1.05  0.75  0.72  0.13  0.90 
* Preparation of the various forms of C3 is described in Materials and Methods. 
$ Percent hemolytic activity compared with C3 in normal human serum. 
§ Measured by spectral change at 412 nm after treatment with DTNB. 
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Fz•.  6.  Separation of native C3 from SH-eontaining, hemolytically inactive forms of C3 and C3b 
by chromatography on organomercurial  agarose. A 1 ml sample of C3 (10 mg) that had become 
77% inactive during storage at -35°G was applied to a  1.5- ×  18-era column of organomercurial 
agarose (Aft-Gel 501, Bio-Rad) equilibrated in VBS. The column was washed with 2 column vol of 
VBS followed by 2 vol of VBS containing t0 mM cysteine. All of the applied hemolytic activity 
eluted just behind a small peak of inactive material gel filtering in the breakthrough.  The specific 
hemolytic activity of the native C3 peak was 97% of the activity of C3 in fresh normal human serum 
and this peak contained 26% of the applied protein. The three peaks of protein were examined by 
polyaerylamide  gel eleetrophoresis in SDS and exhibited the characteristic a and ,8 chain pattern of 
native G3. The cysteine-treated column was regenerated by treatment with 10 mM HgCI2 according 
to the manufacturer's directions. 
eluted material was  that of native C3  and all of the applied activity was recovered. 
Binding of inactive C3  must  have occurred  via the free SH  group  because cysteine 
eluted  the  bound  material  and  pretreatment  of  the  protein  with  iodoacetamide 
prevented  binding.  Organomercurial  agarose  also  binds  other  SH-containing  C3 
derivatives, such as C3(CHaNH2),  C3b, C3bi, and C3d. 
Demonstration of C3b-like Functions of C3(H20)  Generated with  Chaotropic Agents.  C3 
altered by chaotropic agents, by freezing and thawing, or by methylamine treatment 
acquired both structural and functional properties similar to proteolytically generated 
C3b.  Fig.  7 shows  that  C3 modified by repeated freezing and thawing or treatment 
with  KSGN,  guanidine,  or  methylamine  was  capable  of  forming  an  alternative 
pathway C3 convertase. Although the enzyme could be formed with factors B  and D 
and  magnesium  alone,  the  presence  of properdin  or  nephritic  factor  facilitated its 862  INITIATION OF THE  ALTERNATIVE PATHWAY OF COMPLEMENT 
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Fzo. 7.  Formation of C3 convertase by chaotrope-treated and freeze-thawed C3 and inhibition of 
the convertases by antibodies to the C3a domain. The time-course of C3 consumption  by the 
preformed convertases is shown. The enzymes were formed by incubating C3 (treated as indicated) 
with Factors B and D and nephritic  factor in the presence of 0.5 mM MgC12 for 3 min at 37°C. 
Further enzyme formation was blocked by the addition of EDTA. C3b and native C3, because of 
rapid conversion to C3b, were not affected by subsequent addition of antibodies to C3a (&), whereas 
the other convertases were inhibited.  This inhibition demonstrates  that these convertases contain 
molecules bearing the C3a domain. 
demonstration.  In  each  case,  the  enzyme  was  allowed  to  form  during  a  3-min 
incubation  period  after  which  EDTA  was  added  to  prevent  subsequent  enzyme 
formation. Where anti-C3a was used, it was added together with the EDTA. Substrate 
C3 was then added to the reaction mixture and samples were withdrawn  at various 
times for analysis of C3 consumption. The activity of the preformed enzyme could be 
inhibited by antibodies specific for the C3a  domain  in every case except C3b  and 
native C3. C3b was not affected because it does not contain the C3a domain. Native 
C3 was not affected because it was rapidly converted to C3b. Conversion was probably 
initiated  by  the  C3  convertase  formed  from  C3(H20),  traces  of which  are  always 
present in native C3.  Thus  the prevalent enzyme measured was the C3b-containing 
C3 convertase. On the other hand, C3(H20)  is very slowly cleaved by C3 convertases 
(4,  5,  10,  20),  and  thus  it is not  converted to C3b  and  retains the C3a domain.  C3 
inactivated in  the presence of 2.8  M  urea did not  form  a  detectable amount  of C3 
convertase. 
Susceptibility of C3(H20)  to  Cleavage by Factors H  and I.  Fig.  8  demonstrates  that 
C3(H20)  prepared  by  various  treatments  exhibits  the  a  and  fl chain  structure  of 
native  C3.  Treatment  with  Factors  H  and  I  (previously  called  fllH  and  C3b 
inactivator) does not affect the structure of native C3 but it results in cleavage of the 
a' chain  of C3b  into two  fragments of 67,000  and 40,000  mol wt  (a'-67 and  a'-40) 
(14). This cleavage abolishes all of the activities of C3h. In contrast, C3(H~O) prepared 
by freezing and thawing or by KSCN or guanidine treatment was sensitive to Factors 
H  and  I,  but  the  fragmentation  pattern  was  different  from  that  of C3b.  Cleavage 
yielded fragments of 76,000  and  40,000  tool wt  (a-76 and  a-40), indicating that  an 
intact  a  chain  bearing  the  amino  terminal  9,000  mol  wt  C3a  domain  had  been 
cleaved. A  trace of these fragments was seen in the native C3 preparation, probably M.  K.  PANGBURN,  R.  D.  SCHREIBER,  AND  H.  J.  M(0LLER-EBERHARD  863 
Fro.  8.  Gel electrophoresis in SDS of C3, C3b, and C3 hemolytically inactivated by freeze-thaw 
(FT), chaotropic agents, and methylamine. Two samples (10 #g in 60 #1) of each protein are shown, 
the second was treated for 30 min at  37°C with C3b inactivator (Factor I,  17 #g/ml)  and/~IH 
(Factor H, 33/zg/ml). Treatment of C3b with Factors I and H yielded two fragments of the a' chain 
with molecular weights of 67,000  and 40,000  (a'-67 and a'-40).  Cleavage of other hemolytically 
inactive preparations of C3 yielded a-76 and a-40 fragments, indicating a susceptibility to Factors 
I and H  in spite of the presence of the C3a domain on the amino terminal of the a'-67 fragment. 
This result has been interpreted as an indication that a C3b-like conformation was acquired without 
peptide bond scission during the various treatments. 
because  it  had  been  frozen and  thawed  once before electrophoresis.  Although  all 
preparations contained a  small proportion of protein that was resistant  to cleavage, 
the urea-treated sample was the most resistant, which is consistent with the failure of 
this material to form a  C3 convertase. In view of these results, it may be concluded 
that C3(H20) resembles C3(CHaNH2) with respect to all C3b-like functions, including 
susceptibility to attack by Factors H  and I. 
Discussion 
This investigation  (a)  examines the spontaneous transition of C3  to C3b-like C3, 
(b)  describes procedures to accelerate this  transition,  (c)  presents evidence that  the 
alteration  is  due  to  thioester hydrolysis, and  (d)  demonstrates  that  the  product  is 
capable of interacting with alternative pathway components to form a functional C3 
convertase. These observations support the hypothesis (4) that C3(H20) is generated 
spontaneously  in  plasma  and  forms a  C3  convertase that  proteolytically produces 
metastable C3b capable of binding covalently to biological particles. 
The spontaneous decay of C3 hemolytic activity in buffer was found to proceed at 
a rate of 0.2-0.4%/h at 37°C. In the presence of Factors B and D, consumption of C3 864  INITIATION  OF THE ALTERNATIVE PATHWAY OF COMPLEMENT 
was complete in 2 min because of uncontrolled formation of fluid-phase C3 convertase. 
The presence of physiological concentrations of the control proteins, Factors H  and I, 
prevented rapid amplification but allowed C3 consumption to increase to 1%/h. Low 
concentrations of chaotropic  agents  enhanced  the  rate  of spontaneous  C3  decay, 
which  correlated  with  the  rate  of SH  group  liberation.  The  results  support  the 
conclusion that treatment with chaotropes caused the hydrolysis of the thioester in 
native C3  (21).  The proof that water is in fact incorporated into native C3 during 
conversion  to  the  functionally C3b-like  form  must  await  the  demonstration  that 
oxygen-18 is incorporated from H2aso, 
Native  C3  could be  separated  from C3(H20)  and  C3b  by chromatography on 
organomercurial-derivatized agarose. This method takes advantage of the presence of 
a  free SH  group  in  C3(H20)  and  C3b.  The  method has  several  advantages over 
published methods that employ ion-exchange chromatography to separate inactive 
from native C3  (5,  20).  The present method differs from other procedures  in that 
native C3  is  not adsorbed  to  the column, allowing yields approaching  100%. The 
column size has been scaled down to process microgram quantities of protein and the 
elution of native C3 required only minutes. This method should also be applicable to 
C4 and az-macroglobulin, which probably contain similar thioester moieties (22, 23). 
The exploration of the effect of chaotropes on C3 properties was prompted by the 
previous finding (4)  that C3(CHzNHz) exhibited C3b-like functional characteristics, 
including the ability to form a  fluid-phase C3 convertase with Factors B, D, and P. 
The modified protein was susceptible to cleavage and inactivation by Factors H  and 
I. Further, the C3 (CHzNH2)-containing fluid-phase enzyme was capable of depositing 
C3b on the surface of receptive particles. A kinetic analysis of the binding of CHzNH2 
and the resulting conformational transition and appearance of functional sites showed 
the following sequence of events (9). Although methylamine binding and metastable 
binding-site inactivation were rapid (tl/2, 5.5 min), the conformational rearrangement 
of the modified protein was markedly slower. The appearance of the binding site for 
Factor B was also slower than CH3NHz binding (tl/2, 25 min) and the appearance of 
susceptibility to cleavage by Factors H  and I was even further delayed (tl/2, 35 min). 
These observations suggest that the fluid-phase C3 convertase may be formed before 
the modified protein is fully subject to control. 
It was hypothesized previously (4)  that an analogous product of C3, C3(HzO), is 
formed by spontaneous hydrolysis of the internal thioester. The present results support 
this  hypothesis and  suggest  that  the  initial  enzyme of the  alternative pathway is 
formed from spontaneously arising C3(H20). As demonstrated in this study, C3(H20) 
possesses  the  functional  properties  of C3b  and,  like  fluid-phase  C3b,  has  lost  its 
potential to bind  to biological particles.  It is proposed,  therefore, as schematically 
presented in Fig. 9, that the initial event in the alternative pathway is the spontaneous 
generation of C3(H20),  which  is  formed continuously at  a  slow rate.  Due  to  the 
differential rate of appearance of binding sites during the transition to the C3b-like 
form of the molecule, the enzyme C3(H20),Bb  may form and generate metastable 
C3b before the convertase becomes fully susceptible to control by Factors H  and I. 
Deposition of C3b onto biological particles permits the discriminatory ability of C3b 
to be expressed. On nonactivators of the alternative pathway, it is rapidly degraded 
by Factors H  and I. On activators, the affinity of C3b for Factor H  is reduced and M.  K.  PANGBURN,  R.  D.  SCHREIBER,  AND  H. J.  MI]LLER-EBERHARD 
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Fro.  9.  A schematic representation of the proposed molecular dynamics of alternative pathway 
activation  described in  the text.  Initiation results  from spontaneous hydrolysis  of the putative 
thioester in  native C3,  which produces a  C3  molecule with C3b-like  functional properties. The 
resulting C3 convertase [C3(H~D),Bb]  generates metastable C3b.  Deposition of metastable C3b 
occurs  randomly from the fluid phase, but only on activators does the bound C3b escape control 
sufficiently  to  mediate  feedback  amplification, additional  C3b  deposition, and  C5  convertase 
formation. 
degradation is sufficiently retarded to allow C3 convertase formation, amplification, 
and C5 convertase assembly. 
The recognition of C3(H20)  as a  heretofore unknown functional form of C3 and 
the observation that  C3(H20)  arises  spontaneously  may resolve the  long-standing 
question as to the manner in which the alternative pathway is initiated (24-27). 
Summary 
Activation of the alternative pathway of complement commences with the forma- 
tion of an initial fluid-phase C3 convertase. Treatment of C3 with the nucleophilic 
reagent  methylamine  has  previously  been  shown  to  result  in  the  cleavage  of an 
intramolecular thioester bond and to induce C3b-like properties, including the ability 
to  form  a  fluid-phase  C3  convertase.  This  report  examines  the  hypothesis  that 
spontaneous hydrolysis of the thioester generates a derivative of C3 that is responsible 
for the formation of the initial C3 convertase of the alternative pathway. The rate of 
spontaneous decay of C3  hemolytic activity in buffer was found to be between 0.2 
and  0.4%/h.  In  the  presence  of other  alternative  pathway  proteins,  the  rate  of 
inactivation was  1%/h. The rate of spontaneous inactivation was greatly accelerated 
by low concentrations of chaotropic agents such as KSCN or guanidine. Liberation 
of a  sulfhydryl group,  not  present  in  native C3,  correlated with  loss  of hemolytic 
activity, indicating that exposure to chaotropic agents resulted in thioester hydrolysis. 
Unlike  native  C3,  C3  bearing  a  single  reactive  sulfhydryl  group  was  capable  of 866  INITIATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT 
generating fluid-phase  C3 convertase with Factors B, D, and  P  and was cleaved by 
Factor  I  (C3b  inactivator)  in  the  presence  of Factor  H  (fllH).  The  fragmentation 
patterns  indicated that the C3a domain was covalently associated with the function- 
ally C3b-like  C3.  Organomercurial  agarose was employed for the  rapid  removal of 
sulfhydryl-bearing, hemolytically inactive forms of C3 and C3b from native hemolyt- 
ically active C3. 
The authors thank Lisa B. McGuire and Mary Brothers for their excellent technical assistance, 
and Keith Dunn and Nancy Johnson for preparation of the manuscript. 
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